Cytokine oncostatin M (OM) exerts growth-inhibitory and dierentiative eects on breast cancer cells. Previously we showed that the transcription from the p53 gene in breast cancer cells was down regulated by OM. To elucidate the molecular mechanisms underlying the OM eect on p53 transcription, in this study, we dissected the p53 promoter region and analysed the p53 promoter activity in breast tumor cells. We showed that treatment of MCF-7 cells with OM induced a dose-and time-dependent suppression of p53 promoter activity. The p53 promoter activity was decreased to 35% of control at 24 h and further decreased to 20% at 48 h by OM at concentrations of 5 ng/ml and higher. Deletion of the 5'-¯anking region of the p53 promoter from 7426 to 797 did not aect the OM eect. However, further deletion to 740 completely abolished the repressive eect of OM. The p53 promoter region 796 to 741 contains NF-kB and c-myc binding sites, and a newly identi®ed UV-inducible element PE21. Mutations to disrupt NF-kB binding or c-myc binding to the p53 promoter decreased the basal promoter activity without aecting the OM-mediated suppression, whereas mutation at the PE21 motif totally abolished the OM eect. We further demonstrated that insertion of PE21 element upstream of the thymidine kinase minimal promoter generated an OM response analogous to that of the p53 promoter. Finally, we detected the speci®c binding of a nuclear protein with a molecular mass of 87 kDa to the PE21 motif. Taken together, we demonstrate that OM inhibits the transcription of the p53 gene through the PE21 element. Thus, the PE21 element is functionally involved in p53 transcription regulated by UV-induction and OM suppression. Oncogene (2001) 20, 8193 ± 8202.
Introduction
The p53 tumor suppressor protein is involved in several central cellular processes that are critical for maintaining cellular homeostasis, including gene transcription (Nakano et al., 2000; Xu et al., 2000) , DNA repair (Kao et al., 2000; Zhu et al., 2000) , cell cycling (Jey et al., 2000; Hirose et al., 2001) , senescence (Peeper et al., 2001; Seluanov et al., 2001) , and apoptosis (Uberti and Grilli, 2000; Zeng et al., 2000) . Compared to the vast information and knowledge available regarding the regulation of p53 protein expression and function (Wang and Friedman, 2000; Ito et al., 2001; Wang et al., 2001) , there is only a small amount of literature on transcriptional regulation of the p53 gene (Balint and Reisman, 1996; Benoit et al., 2000; Mokdad-Gargouri et al., 2001) . However, control of p53 gene expression at the transcriptional level has been shown to play important roles in mitogenic stimulation or factor induced dierentiation (Reich and Levine, 1984; Soini et al., 1992; ) . Moreover, the deregulated transcription of p53 accounts for at least in part, the elevated expression of mutant p53 in tumor cells (Balint and Reisman, 1996) .
Since cloning of the human p53 promoter in 1989 (Tuck and Craword, 1989) , several transcription factors have been identi®ed that interact with speci®c regions of the p53 promoter to positively or negatively regulate transcription. The transcription factors shown to positively regulate p53 transcription include c-myc (Kirch et al., 1999; Lee and Rho, 2000) , NF-kB (Pei et al., 1999; Benoit et al., 2000) , YY1/NF1 (Lee et al., 1998 (Lee et al., , 1999 Nayak and Das, 1999) , Ap1 (Kirch et al., 1999) , and the HoxA5 homeobox containing gene product (Raman et al., 2000) . Members of the PAX family are the only mammalian nuclear proteins shown to repress p53 transcription through a binding site present in the ®rst non-coding exon (Stuart et al., 1995) .
Recently, a novel 21 bp motif, named the PE21 element, was identi®ed in the human p53 promoter that is located immediately upsteam of the NF-kB binding site (Noda et al., 2000) . It was shown that the PE21 element covering the region of 779 to 759 is a primary determinant for the basal transcription of the p53 gene and the sequence required for UV-induced transcription in human ®broblasts. Mutations within this region drastically reduced the basal promoter activity and abolished the UV-induction. Interestingly, this 21 bp motif appears to have a function in initiation of transcription in a bi-directional manner. Insertion of multiple copies of PE21 in the sense or antisense orientiation into a promoterless luciferase reporter pGL2-basic initiated the transcription of the luciferase gene and generated an UV-inducible response as well. It remains to be elucidated whether the PE21 element has a functional role in p53 transcription regulated by cellular factors or other extracellular stimuli. Furthermore, the PE21 binding proteins need to be identi®ed and characterized.
Oncostatin M (OM), a 28 kDa glycoprotein, is a cytokine produced by activated T lymphocytes and macrophages (Zarling et al., 1986) . Previous studies showed that OM inhibits the growth of several breast cancer cell lines, including MCF-7, MDA-MB231, and H3922, which is a cell line derived from an in®ltrating ductal carcinoma (Horn et al., 1990; Douglas et al., 1997 Douglas et al., , 1998 Liu et al., 1997; Spence et al., 1997) . Breast cancer cells respond to OM treatment with reduced growth rates and the appearance of dierentiated phenotypes. However, OM treatment does not appear to lead to apoptosis. Since the p53 tumor suppressor protein plays important roles in cellular proliferation and dierentiation, we examined the eects of OM on p53 expression in breast cancer cells. Surprisingly, we found that p53 expression was down regulated by OM in MCF-7, MDA-MB231, and H3922 cells (Liu et al., 1999) . Decreased levels of p53 protein and mRNA were detected after 1 day of OM treatment and reached maximal suppression of 10 ± 20% of control after 3 days in H3922 cells. Nuclear run-on assays further demonstrated that OM decreased the number of actively transcribed p53 mRNA. These studies suggest that OM may repress p53 gene transcription. The eect of OM on p53 transcription appears to precede its eects on cell growth inhibition and induction of morphological changes, as the retardation of cell growth by OM as measured by [
3 H]-thymidine incorporation could be detected after 2 days but a decrease in the level of p53 mRNA could be detected as early as 6 ± 8 h.
In order to delineate the molecular mechanisms by which OM regulates p53 transcription and to understand the relationship between p53 expression and proliferation and dierentiation of breast cancer cells, in this study we dissected the p53 promoter region to identify the cis-acting element that mediates the OM eect in MCF-7 cells. Our results demonstrate that the eect of OM is not mediated through the known repressor PAX binding site. Instead the PE21 element is responsible for OM-induced suppression of p53 transcription. Mutation of PE21 in the context of the p53 promoter completely abolished the inhibitory activity of OM on p53 transcription. By contrast, insertion of the PE21 motif into an OM-unresponsive TK promoter created a phenomenon of transcriptional suppression, resembling the p53 promoter.
Results
Deletion analysis to define the regulatory sequences involved in the basal transcriptional activity of the p53 promoter in breast tumor cells
The regulatory sequences that control p53 transcription in breast tumor cells have not been clearly de®ned, although a number of studies had examined p53 promoter activity in other cell types. Thus, initially in the present study, we generated a series of reporter constructs in which luciferase gene is driven by varying lengths of the 5'-¯anking region of the p53 gene. These constructs were tested for activity in MCF-7 cells. A diagram of the deletion constructs is shown in Figure  1 . Figure 2a compared the basal promoter activity of the deletion constructs with the activity of the full promoter construct pGL3-p53Luc that contains a 599 bp fragment of the p53 promoter (7426 to+172) (Liu et al., 1999) . These results, representing 6 ± 8 separate transfections, showed that deletion of the 5'-anking region from 7426 to 7177 did not aect the p53 promoter activity, whereas deletion down to 797 (5' Del-4) signi®cantly lowered the basal activity to approximately 40% of the full promoter. Further deletion to 741 (5' Del-5) to eliminate the binding sites for NF-kB and c-myc drastically reduced the basal promoter activity to a level below 5% of the full promoter. These data suggest that the transcription factors NF-kB and c-myc play critical roles in the basal transcriptional activity of the p53 gene in breast tumor cells, however, the promoter region covering 7176 to 797 may contain a regulatory sequence that is responsible for the maximal basal transcriptional activity of the p53 gene in MCF-7 cells.
The p53 promoter region from 7176 to 797 contains a stretch of CT rich sequence (CCCTCCTCCCC 7174 to 7164), a potential binding site for the transcription factor Sp1. To determine whether Sp1 interacts with this sequence, electrophoretic mobility shift assay (EMSA) was conducted with the nuclear extract isolated from MCF-7 cells and a 32 P-labeled double-stranded oligonucleotide, p53-Sp1, corresponding to the promoter region 7183 to 7154. Upon incubation of p53-Sp1 with nuclear extract, two DNA-protein complexes were detected (Figure 2b , lane 1). Formation of these complexes was inhibited by competition with a 100-fold molar excess of the unlabeled probe p53-Sp1 (lane 2), but was not inhibited by the oligonucleotide p53-mSp1 that contains mutations within the CT-stretch (lane 3).
The faster moving complex was supershifted by the anti-Sp3 antibody (lane 5), whereas the slower moving complex was partially supershifted by the anti-Sp1 antibody (lane 4). Inclusion of anti-Sp1 and anti-Sp3 antibodies together in the reaction mixture completely supershifted both complexes (lane 6). These data demonstrate that transcription factors Sp1 and Sp3 bind to this CT-rich region of the p53 promoter.
To determine the function of Sp1/Sp3 in mediating the p53 basal promoter activity, the Sp1 site in p53Luc was mutated (CCCTCCTCCCC to CGCTCGTCGCC) and the mutated reporter p53Luc-mSp1 along with the wild type vector p53Luc were transfected into MCF-7 cells. Figure  2c shows that mutation of this Sp1 site lowered the p53 promoter activity by approximately 50%, thereby suggesting that loss of the Sp1/Sp3 binding to the CT-rich region is primarily responsible for the diminished basal promoter activity of the deletion mutant 5' Del-4. These results together demonstrate that Sp1 and Sp3 are positive trans-activators of p53 transcription and that their binding to the CT rich sequence contributes to the basal transcriptional activity of the p53 gene.
Dose-dependent and time-dependent responses of p53 transcription to OM
Next, the eect of OM on p53 promoter activity in MCF-7 cells was examined. The full promoter construct p53Luc was transiently transfected into MCF-7 cells along with the renilla luciferase expression vector pRL-TK. After transfection, cells were untreated or treated with OM at dierent concentrations for 48 h. Figure 3a shows that the suppressive eect of OM on p53 promoter activity was detected at 0.1 ng/ml, and a maximal suppression of 75 ± 80% of p53 promoter activity was observed at 5 ng/ml. The inhibitory eect of OM on p53 transcription was also time-dependent. The p53 promoter activity was decreased to 67% of control by 8 h, lowered to 35% by 24 h, and further declined to 20% of control by 48 h after treating cells with a saturable concentration of OM. These results clearly demonstrate that OM represses p53 promoter activity in a dose-dependent and a time-dependent manner that is directly correlated with the eects of OM on p53 mRNA expression, as we previously reported (Liu et al., 1999) .
The biological functions of OM can be mediated through two types of receptor complexes, the leukemia inhibitory factor (LIF)/OM shared receptor (type I) and the OM-speci®c receptor (type II). Previous studies have shown that MCF-7 cells express both the type I and the type II receptors of OM (Estrov et al., 1995) . To determine which receptor complex mediates the eect of OM on p53 transcription, we compared the eect of OM with that of LIF on p53 promoter activity. As shown in Figure 4 , in contrast to the strong inhibitory eect of OM, LIF at saturable concentrations (50 and 100 ng/ml) had no eect at all on the activity of p53 promoter p53Luc, thereby implying that OM regulates the transcription of the p53 gene mainly through the type II OM-speci®c receptor not the OM/ LIF shared receptor type I complex.
Dissection of the p53 promoter to define the OM-responsive region
To de®ne the OM-responsive region in the p53 promoter, the 5' and 3' deletion constructs of the p53 Figure 1 Schematic representation of p53 promoter luciferase reporter plasmid. A 599 bp fragment of the p53 gene covering 7426 to +172 was inserted into 5' KpnI and 3' BglII sites of the promoter-less luciferase reporter pGL3-basic. The 5' deletion fragments of the p53 promoter were synthesized by PCR using pGL3-p53Luc as the template. The p53 promoter fragments were inserted into 5' SacI and 3' XhoI sites of pGL3-basic. The most 3' end of the major transcription initiation site for the human p53 gene is de®ned as +1 and the locations of the 5' ends of the promoters are indicated by the negative numbers of nucleotides relative to the transcription start site promoter were transfected into MCF-7 cells. Then the transfected cells were untreated or treated with OM for 40 h prior to cell lysis. The results of 6 ± 8 transfection assays using 5' deletion constructs are summarized in Figure 5 . These results showed that deletion of the 5'-anking region from 7426 to 797 did not aect the OM response. In contrast, further deletion to 741 (5' Del-5) eliminated the OM eect. These data suggest that the promoter region covering 796 to 740 is not only important for the basal transcriptional activity as shown in Figure 2a but it may also contain the critical OM-responsive element. Furthermore, shortening of the 3' region from +172 to +14 to delete the PAX binding site had no eect on OM-mediated suppression or the basal promoter activity, thereby excluding the involvement of the repressor PAX in OM-mediated down regulation of p53 transcription (data not shown). Cell lysate was harvested 40 h after transfection. The normalized luciferase activity of p53Luc is expressed as 100%. The data (mean+s.d.) shown are derived from 6 ± 8 separate transfection experiments in which triplicate wells were assayed. (b) EMSA: A double stranded oligonucleotide corresponding to the p53 promoter region 7183 to 7154, designated as p53-Sp1, was radiolabeled and incubated with 10 mg of nuclear extract prepared from MCF-7 cell in the absence (lane 1) or in the presence of 100-fold molar unlabeled competitors (lanes 2, 3), or in the presence of antibodies (lanes 4 ± 6). The reaction mixture was loaded onto a 6% polyacrylamide gel and run in TGE buer at 30 mA for 2.5 h at 48C. (c) Mutation analysis: p53Luc-wt and p53Luc-mSp1 were transiently transfected into MCF-7 along with the vector pRL-TK. The normalized luciferase activity of p53Luc-wt is expressed as 100%. The p53Luc-mSp1 exhibited 54.1% activity compared with p53Luc-wt Localization of the OM-responsive sequence to the PE21 element
The 5' deletion analysis localized the OM-responsive sequence to the proximal region of the p53 promoter from 796 to 741. This region contains three important regulatory motifs including NF-kB, the Ebox (c-myc), and the newly identi®ed UV-inducible PE21 element. To investigate the role of these regulatory sequences in OM-mediated suppression, site-directed mutagenesis was conducted on the full promoter p53Luc to mutate each binding site individually. Figure 6 shows that mutation of the c-myc site lowered the basal promoter activity 75% without aecting the OM eect. Likewise, mutation of the NF-kB binding site decreased the basal promoter activity 85% with little eect on OM. By contrast, mutation at the PE21 element drastically reduced the basal promoter activity and rendered the p53 promoter unresponsive to OM. To con®rm this ®nding, the PE21 element was mutated in the vector 5' Del-4 that contains the minimal sequence for the basal transcription and the OM-mediated suppression. Again, the OM inhibitory eect was not observed in the PE21 mutant in the context of this short promoter fragment. Similarly, the suppressive eect of OM was not seen on the plasmid 5' Del-4b in which the PE21 element was deleted.
Next, we were interested in determining whether OM could exert its eect on PE21 in the context of a heterologous promoter that contains the PE21 element without auxiliary sequences of p53 promoter. To test this, luciferase reporters containing dierent copies of PE21 in tandem inserted 5' upstream of a minimal HSV tk promoter (pTKLuc) in either sense, pTKLuc-PE21 (S), or antisense, pTKLuc-PE21 (As) orientations were transfected into MCF-7 cells. The plasmid pTKLuc produced low but measurable luciferase activity in MCF-7 cells and OM treatment did not lower the activity. Inclusion of the PE21 sequence in either direction greatly increased luciferase activities from 20 ± 400-fold of the pTKLuc. The fold increase of luciferase activity was correlated with the increase in PE21 copy number in most cases and showed a preference with the antisense orientation. Importantly, in contrast to the vector pTKLuc, the reporters containing the PE21 element clearly displayed responses to OM with luciferase activities reduced to 39 to 59% of control in the OM treated cells (Figure  7 ), comparable to the OM eect observed in the native p53 promoter. Together, our results presented in Figures 6 and 7 provide strong evidence that the PE21 element plays an important role in the basal transcription of the p53 gene and is also critically involved in the OM-induced transcriptional suppression of the p53 gene in breast cancer cells.
Characterization of nuclear proteins that interact with the PE21 element
To detect nuclear proteins in MCF-7 cells that speci®cally interact with the PE21 sequence, EMSA was conducted with 32 P-labeled oligonucleotide p53-PE21 containing the PE21 and¯anking sequence, and nuclear extracts prepared from untreated or OM 40 htreated cells. Figure 8 shows that three speci®c complexes were detected in both control and OMtreated nuclear extracts. The formation of these complexes was inhibited with 100-fold molar excess of unlabeled probe (lanes 2, 7) but was not inhibited by a 100-fold molar excess of an unrelated DNA containing an estrogen response element (lanes 5, 10). An oligonucleotide containing the NF-kB site of the p53 Figure 4 Comparison of inhibitory eect of OM and LIF on p53 promoter activity. MCF-7 cells were transfected with p53Luc along with the vector pRL-TK. After addition of DNA into the medium, OM or LIF at indicated concentrations were added to the cells and cells were harvested 40 h later Figure 5 The proximal region of the p53 promoter contains an OM-responsive element. P53Luc and 5' deletion constructs containing various lengths of the promoter were transfected into MCF-7 cells along with the vector pRL-TK. After transfection, cells were incubated in the presence or absence of OM 50 ng/ml for 24 h. The normalized luciferase activity of transfected cells that were untreated is expressed as 100%. The data (mean+s.e.) shown were derived from 6 ± 8 independent transfection assays. Dierences in normalized luciferase activities between untreated and OM treated samples were evaluated using two tailed Student's t-test. A statistically signi®cant dierence (P50.05) is indicated by an asterisk promoter competed for the binding of complex A but not complexes B and C (lanes 4, 9). The binding of complex A was also competed by oligonucleotide p53-mPE21 that contains a 3 bp mutation within the PE21 sequence (lanes 3, 8) . These data suggest that the complex A was formed at sequences that¯ank the PE21 core element. Thus, the identity of complex A was not further investigated in this study since the emphasis of this study is on the PE21 core element.
Complexes B and C are PE21 speci®c as the oligonucleotide p53-mPE21 lost the ability to compete with the binding of these two complexes to the labeled PE21 probe. Apparently OM treatment of 40 h did not altered the pattern of the complexes or the intensity of the binding signals. Similar results were obtained with the nuclear extracts treated with OM for dierent length of times including 6 and 24 h. These observations were consistent with previous results of UV-induction. It was shown that the binding of nuclear proteins of ®broblasts without or with UV-irradiation to the PE21 probe was not dierent (Noda et al., 2000) .
Previous studies conducted in human ®broblasts did not characterize the protein/DNA complex of the PE21 sequence. It is unknown whether a single DNA binding protein or multiple proteins interact with the PE21 motif. To characterize the MCF-7 nuclear proteins present in the PE21 DNA complexes, EMSA with MCF-7 nuclear extract and the labeled PE21 probe was followed by UV cross-linking. Complex B was excised from the gel and the protein components were analysed by denaturing SDS-polyacrylamide gel electrophoresis (SDS ± PAGE). Figure 6 Localization of the OM response to the PE21 element in the human p53 promoter. P53 promoter reporter wild type and mutants were transfected into MCF-7 cells individually. After transfection, cells were incubated in the presence or absence of OM (50 ng/ml) for 40 h. The data represent the results of 6 ± 8 independent transfections. The normalized luciferase activity of each vector was expressed as the per cent of luciferase activity of p53Luc wild type vector in untreated control cells. An asterisk sign indicates that there is a statistically signi®cant dierence between the untreated control and the OM treated sample Figure 7 Eects of OM on heterologous promoter constructs containing the PE21 element. The pTKLuc-PE21 vectors were constructed by insertion of sequences of the PE21 element in tandem in sense (S) or antisense (As) orientation adjacent and upstream of the TATA box from the HSV tk promoter. The number indicates the number of repeat of the PE21 element in each construct. These vectors were transiently transfected into MCF-7 cells and examined for responses to OM treatment as described in Figure 5 . The data shown are representative of 3 ± 4 separate transfections Figure 8 EMSA analysis of nuclear proteins interacting with the PE21 motif. A double stranded oligonucleotide, designated as p53-PE21, was radiolabeled and incubated with 10 mg of nuclear extracts prepared from untreated (lanes 1 ± 5) or OM 40 h treated MCF-7 cell (lanes 6 ± 10) in the absence (lanes 1, 6) or in the presence of 100-fold molar unlabeled competitors. The reaction mixture was loaded onto a 6% polyacrylamide gel and run in TGE buer at 30 mA for 2.5 h at 48C Analysis of the SDS ± PAGE revealed that one protein was crosslinked to the labeled PE21 probe (Figure 9 ). After correction for the bound oligonucleotide, the molecular mass of the protein appeared to be 87 kDa. A similar procedure was used to characterize complex C, but the UV-crosslinking experiments failed to detect any proteins present in the complex C, probably due to the low abundance of the complex and low eciency of the UV-crosslinking.
Discussion
The PE21 element was originally discovered by searching for the sequence that was responsible for the UV-induced transcription of the p53 gene in human ®broblasts (Noda et al., 2000) . Intriguingly, in this study, we found that the repressive eect of OM on p53 transcription was also mediated through this regulatory element. Our studies further highlight the importance of the PE21 element in the control of p53 gene transcription.
Our studies clearly demonstrate that the PE21 element is a critical sequence that controls p53 transcription in breast cancer cells, as mutation of this sequence produced the severest impact on p53 promoter activity in MCF-7 cells as compared to mutations on other functional sites such as NF-kB or the bHLH c-myc binding site. Mutations to disrupt the binding of NF-kB to its recognition sequence adjacent to PE21 lowered the basal promoter activity to 15% of the wild type promoter; mutation of the basic HLH site to interfere the binding of c-myc reduced the basal transcription by 75%. In contrast, alteration of 3 bp within the PE21 motif nearly eliminated the transcriptional activity of the p53 promoter. The promoter activity with the PE21 mutant was less than 5% of the wild type promoter. The ability of PE21 in activation of gene transcription was further demonstrated by its strong inducing eect on pTKLuc that contains a weak promoter composed a TATA box and one nonfunctional Sp1 site.
In this study we showed that mutations of the PE21 element in the context of the full p53 promoter (p53Luc) or in the context of the short promoter fragment (5' Del-4) that retains 40% of the p53 promoter activity completely eliminated the inhibitory eect of OM on p53 transcription. In contrast, mutations at other functional sites including NF-kB or c-myc did not abolish the OM inhibitory activity. The critical role of the PE21 site in OM-mediated repression of p53 transcription is further supported by the results of transfection with the pTKLuc-PE21 reporters. OM had no eect on the promoter activity of pTKLuc. However, the promoter activities of pTKLuc-PE21 in either the sense or antisense orientation were clearly suppressed by OM to levels comparable to that observed in the p53 promoter. These results suggest that the PE21 element is the primary cis-acting sequence that mediates the OMinduced transcriptional repression of the p53 gene.
We were able to detect two DNA-protein complexes formed with the PE21 sequence from MCF-7 cells. Complex B was relatively more abundant than complex C. EMSA experiments followed by UV-cross linking and SDS ± PAGE revealed that a nuclear protein with a molecular mass around 87 kDa was present in complex B. Interestingly, in an eort to purify the PE21 binding proteins, two proteins with molecular weights of 80 and 85 kDa were isolated from Molt 4 cells through PE21-sepharose anity column. These two proteins were shown to speci®cally bind to the PE21 probe (Noda et al., unpublished data) . It is possible that the 87 kDa protein present in the complex B is identical or related to one of these two PE21 binding proteins. The relationship between complexes B and C is presently unknown. It is highly likely that more than one nuclear protein binds to the PE21 sequence. Alternatively, the faster moving complex C may represent a degradation product of the protein in complex B.
OM treatment did not alter the binding of nuclear proteins to PE21; the same two complexes were detected in the OM-treated sample as in the control. This result is not totally surprising as the previous studies with UV-induction did not detect a dierent binding pattern with the PE21 sequence and nuclear extracts isolated from UV-irradiated and non irradiated ®broblasts (Noda et al., 2000) . Our results combined with the prior study suggest that regulation of p53 transcription through the PE21 element by OM is mediated by mechanisms other than direct alteration of the DNA binding activity of the PE21 interacting proteins. It is possible that there are other cofactors associated with the PE21 binding protein. OM treatment could interfere with this association. The inability to detect changes of DNA binding activities of transcription factors to a functional regulatory element by gel shift assays has been described in other promoter studies. For example, the transcription of p21 WAF1/CIP1 gene is activated by TGFb, phobol esters, and histone deacetylase inhibitors through a Sp1 site proximal to the p21 promoter. However, none of these activators altered the DNA binding activity of Sp1 (Datto et al., 1995; Briggs et al., 1996; Sowa et al., 1997; Huang et al., 2000) .
Previous studies have de®ned the p53 promoter as a TATA-less and GC-rich less promoter, as the TATAbox and GC-rich sequence are not present in the proximal promoter region of the p53 gene (Tuck and Craword, 1989) . However, our studies with deletion and mutation analysis identi®ed a novel Sp1/Sp3 binding site that covers the regions 7174 to 7165 of the p53 promoter. This Sp1 binding site is expendable for OM-mediated suppression of p53 transcription but is important for the basal transcriptional activity of p53 gene. Mutation or deletion of this CT-rich sequence decreased p53 promoter activity by 50 ± 60%. The involvement of Sp1/Sp3 in p53 transcription is further demonstrated by our EMSA supershift assay that clearly showed Sp1 and Sp3 binding to this region. Therefore, it is highly likely that Sp1 as a ubiquitously expressed transcription factor has a functional role in p53 gene transcription.
In summary, our studies demonstrate that p53 transcription is down regulated by OM in growthinhibited and dierentiated breast cancer cells. The PE21 element mediates this repressive eect. It is interesting to speculate that the activities of several dierent intracellular signal transduction pathways converge at the PE21 element. The UV-induced activation of p53 transcription is linked to a stress signal. The OM-induced suppression likely involves the MAP kinase ERK pathway, as we have found that the eects of OM on p53 protein expression and on p53 promoter activity can be partially blocked by the MEK inhibitor PD98059 (Liu et al., 1999) . Further studies to identify and characterize the PE21 element binding proteins will greatly facilitate the understanding of the role of the PE21 site in the control of p53 transcription and its connection to intracellular signaling in normal cells as well as in tumor cells.
Materials and methods

Cells and reagent
The human breast cancer cell line MCF-7 was obtained from American Type Culture Collection (Manassas, VA, USA) and cultured in RPMI-1640 medium supplemented with 10% heat inactivated fetal bovine serum (FBS). Human recombinant OM and LIF were purchased from the R&D systems (Minneapolis, MN, USA).
P53 promoter luciferase reporters
pGL3-p53Luc contains a 599 bp fragment of the human p53 promoter region and exon 1 (7426 to +172) (Liu et al., 1999) . To construct 5' Del-1 (7329 to +172), the pGL3-p53Luc was digested with restriction enzyme HindIII. The DNA fragment was isolated and subcloned into the HindIII site of pGL3-basic vector. Additional 5' and 3' deletion constructs were made by PCR with pGL3-p53Luc as the template. Table 1 describes the primer sequence of oligonucleotides utilized in the deletion and mutation analysis, as well as in EMSAs.
Transient transfection and luciferase assay
MCF-7 cells were plated at a density of 80 000 cells/well in 24-well plates and incubated for 24 h. Cells were cotransfected with 90 ng of various p53 promoter reporter plasmids and 10 ng of a pRL-TK as a normalizing vector per well by using Eectene transfection reagent (Qiagen). Transfected cells were incubated with human recombinant OM at a saturable concentration of 50 ng/ml or the OM dilution buer (BSA 1 mg/ml in PBS) for 40 h prior to cell lysis. Luciferase activities were measured using the Promega Dual Luciferase Assay System. All the measured ®re¯y luciferase activity of the plasmid constructs was divided by the renilla 
Electrophoretic mobility shift assays (EMSA)
Nuclear extracts of MCF-7 cells were prepared as previously described (Liu et al., 2000) . Ten micrograms of nuclear extract were incubated with a 32 P-labeled 27 bp oligonucleotide containing the PE21 sequence for 15 min at RT and loaded onto 6% polyacrylamide gels and run in TGE buer at 30 mA for 2.5 h at 48C. The gels were dried and visualized on a PhosphorImager. For UV-cross-linking, after electrophoresis, the wet gel was exposed to a short-wave UV box from a distance of 2 ± 3 cm at 48C for 1 h as previously described (Phan et al., 1996) . Then, the wet gel was brie¯y exposed to a PhosphoImager screen to locate the complexes. The region of the gel containing complex B was cut out, and the proteins were eluted at room temperature overnight in elution buer containing 50 mM Tris-HCL (pH 7.9), 0.1% SDS, 0.1 mM EDTA, 5 mM DTT, 150 mM NaCl, and 50 mg/ ml gamma-globulin. The eluted protein was precipitated with four volumes of dry ice-cold acetone, washed with ethanol, and air-dried. After resuspension in Laemmili loading buer and heating, SDS-polyacrylamide gel electrophoresis was performed and the labeled protein was visualized by a PhosphorImager.
Abbreviations EMSA, electrophoretic mobility shift assay; FBS, fetal bovine serum; LIF, leukemia inhibitory factor; OM, oncostatin M; TK, thymidine kinase
